期刊文献+

bmi-1shRNA逆转录病毒表达载体的构建及稳定转染LoVo细胞系的建立 被引量:3

Construction of Retrovirus-mediated shRNA Expression Vector Targeting bmi-1 and Establishment of Stable Transfected LoVo Cell Line
在线阅读 下载PDF
导出
摘要 目的构建针对原癌基因bmi-1的shRNA逆转录病毒表达载体,建立稳定转染的LoVo细胞系,探讨稳定转染bmi-1shRNA对大肠癌细胞LoVo靶基因表达的影响,为下一步应用RNAi技术治疗打下基础。方法设计合成靶向bmi-1基因编码短发夹RNA的两条寡核苷酸序列,另设计无义对照序列,构建重组载体pSIREN-bmi-1及pSIREN-bmi-1-C,载体经脂质体2000介导转染LoVo细胞,通过嘌呤霉素筛选,建立稳定转染的LoVo细胞系,显微镜观察、MTT检测、荧光定量PCR、Western blot检测bmi-1表达受抑后对细胞的增殖影响。结果成功构建了针对bmi-1基因的shRNA表达载体,建立了稳定转染的LoVo细胞系,bmi-1shRNA对LoVo细胞bmi-1mRNA表达抑制率为80%、bmi-1蛋白抑制率为82%,P<0.05。结论针对bmi-1基因的shRNA表达载体能够明显抑制结肠癌细胞LoVo的增殖能力,bmi-1mRNA与蛋白表达受抑制,但对细胞形态学无明显影响。 Objective To construct Retrovirus-mediated shRNA expression vector targeting bmi- 1, which could transfect LoVo cells so as to establish stable LoVo cell line and to investigate the effect of stable expression brni-lshRNA in LoVo cells, paving the way for further application in RNAi gene therapy. Methods According to the principles of RNA interference technology, we designed and constructed the complementary oligonucleotides encoding hairpin RNA which specifically targets bmi-1 gene. The nonsense oligonucleotides were also designed and constructed. Then, we transfected them into colon cancer LoVo cells by lipofectamineTM 2000. After screening culture by puromycin, stable transfected LoVo cell line was established. We observed the proliferationchange of stable transfected LoVo cell line after the inhibition of bmi-1 by microscope, MTT, fluorescence quantitative PCR and Western blot. Results The vectors expressing shRNA targeting bmi-1 was constructed successfully. Stable transfected LoVo cell line was established. The rate of inhibition on bmi-1 mRNA is 80% and the rate of suppression on bmi-1 protein is 82%(P〈0. 05). Conchtsion The vectors expressing shRNA targeting bmi-1 can inhibit cellular proliferation and bmi-1 gene expression, but the vectors had no obvious affects on cell morphology.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第3期269-273,共5页 Cancer Research on Prevention and Treatment
基金 广州市科技计划资助项目(2007J1-C0091 2008J1-C0171)
关键词 BMI-1基因 RNA干扰 结肠癌细胞 转染 短发夹RNA bmi- 1 RNA interference Colorectal cancer Transfection shR-NA
  • 相关文献

参考文献15

  • 1Kim JH, Yoon SY, Kim CN, et al. The bmi -1 oncoprotein is overexpressed in human colorectal eancer and correlates with the reduced p16INK4a/p14ARE proteins [J]. Cancer Lett, 2004,203(2) :217-224.
  • 2杜利力,韩春山,于晓丽,程晓峰.靶向XIAP的siRNA抑制结肠癌LoVo细胞体内外的增殖[J].中国肿瘤生物治疗杂志,2009,16(5):479-483. 被引量:3
  • 3Jacobs J J, Kieboom K, Marino S, et al. The oneogene and Polycomb-group gene bmi-1 regulates cell proliferation and senes cence through the ink4a Iocus[J ]. Nature, 1999,397 (6715 ) 164 -168.
  • 4Jaeobs JJ, Scheijen B, Vonken JW, et al. bmi-1 collaborates with c-myc in tumorigenesis by inhibiting c-myc-induced apoptosis via INK4A/ARF[J]. Genes Dev, 1999,3(9):2678-2690.
  • 5Kang EY, Choi YJ, Choi YL, et al. Overexpression of bmi-1 oncoprotein correlates with improved survival in breast carcinoma [J]. Breast Cancer Research & Treatment, 2006, 100 ( Suppll ) : S266.
  • 6Wang H, Pan K,Zhang HK, et al. Increased polycomb-group oncogene bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2008, 134(5) :535-541.
  • 7Vonlanthen S, Heighway J, Altermatt HJ, et al. The Bmi- 1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells[J]. Cancer Res, 2002,62 (16) : 4736- 4745.
  • 8黄丽芳,李君君,孔卫红,颜家运.RNA干扰PCGF4/Bmi-1抑制白血病K562细胞系增殖[J].陕西医学杂志,2007,36(3):296-299. 被引量:5
  • 9Fire A,Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998,391 (6669) :806-811.
  • 10Pdadison PJ, Caudy AA, Bernstein E, et al. Short hairpin RNAs(shRNAs)induce sequence-specific silencing in mammalian cell [J]. Genes Dev,2002,16(8) :948-958.

二级参考文献28

共引文献6

同被引文献49

  • 1Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J]. Nature, 1998,391 (6669) :806-811.
  • 2Lipardi C, Wei Q, Paterson BM. RNAi as random degradative PCR siRNA primers convert mRNA into dsRNA that are degraded to generate new siRNAs [ J ]. Cell,2001,107 (3) :297-307.
  • 3Wang z, Li L. Adenovirus-mediated interference against collagen specific molecular chaperone 47-kDa heat shock protein suppresses scar formation on mouse wounds [ J ]. Cell Biol Int, 2008,32 (5) : 484-483.
  • 4Durcan N, Murphy C, Cryan SA. Inhalable siRNA : potential as a therapeutic agent in the lungs [ J ]. Mol Pharm, 2008, 5 (4):559-566.
  • 5Honma K, Takeshita F, Ochiya T. Application of atelocollagen me- diated siRNA delivery for RNAi therapies [ J ]. Yakugaku Zasshi, 2007,127 (5) :807-812.
  • 6Aigner A. Gene silencing through RNA interference ( RNAi ) in vi- vo:strategies based on the direct application of siRNAs [ J ]. J Bio- techno1.2006,124( 1 ) : 12-25.
  • 7Xie FY, Woodle MC, Lu PY. Harnessing in vivo siRNA delivery ior drug discovery and therapeutic development [ J ]. Drug Discov To- day,2006,11 (1/2) :67-73.
  • 8Takeshita F, Minakuchi Y, Nagahara S, et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocol- lagen in vivo [ J ]. Proc Natl Acad Sci USA, 2005,102 ( 34 ) : 12177-12182.
  • 9Uchida H,Tanaka T, Sasaki K, et al. Adenovims-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo [ J ]. Mol Ther,2004,10 ( 1 ) : 162-170.
  • 10Mazor M, Kawano Y, Zhu H, et al. Inhibition of glycogen syn-thase kinase-3 represses androgen receptor activity and prostate cancer cell growth[ J]. Oncogene,2004,23 (47) :7882-7892.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部